The global coronavirus disease 2019 (COVID-19) pandemic originating from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has exerted profound damage to millions of lives. Baicalein is a flavonoid that has gotten a lot of attention as a possible SARS-CoV-2 main protease (M) inhibitor because it can fight off many different viruses. We prepared and screened three sets of databases, each containing 2563 baicalein analogues, against M using molecular docking simulation. The data showed that several baicalein analogues exhibited stable binding energies relative to standard baicalein, indicating that they have some selectivity against M. The binding properties of the top three stable analogues from each database were further analyzed with respect to their binding properties, such as binding mode, binding energy, and binding interaction of putative stable ligand confirmations at the target binding site region.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11252611 | PMC |
| http://dx.doi.org/10.1016/j.dib.2024.110618 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
[Comparative study on metabolites in rat liver microsomes, urine, feces and bile between Shuganning Injection and Scutellariae Radix extract].
Zhongguo Zhong Yao Za Zhi
December 2024
School of Pharmaceutical Sciences, Guizhou Medical University Guiyang 550004, China Engineering Research Center for Development and Application of Ethnic Medicine and Traditional Chinese Medicine, Guizhou Medical University Guiyang 550004, China.
This study aims to compare the metabolic differences of baicalin and its analogues between Shuganning Injection and Scutellariae Radix extract. Twelve SD rats were randomly divided into a Shuganning Injection group and a Scutellariae Radix extract group, with 6 rats in each group. Their liver microsomes were incubated with the drugs, and then the samples were collected.
View Article and Find Full Text PDFEnhanced targeting efficacy of baicalein analogues on the dimeric state of SARS-CoV-2 3CL protease compared to monomeric state.
J Biomol Struct Dyn
December 2024
Department of Pharmacognosy, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Alkharj, Saudi Arabia.
The COVID-19 pandemic caused by the novel coronavirus, SARS-CoV-2, has been a global threat affecting the entire world. It is a single-stranded RNA virus that belongs to the coronavirus family. In SARS-CoV2, the 3CL protease protein significantly contributes to viral replication and is responsible for viral polyprotein cleavage.
View Article and Find Full Text PDFCarboxymethyl chitosan-modified folate-targeted carbon nanotubes-baicalin complexes for cancer progression and metastasis.
Int J Biol Macromol
December 2024
Department of Stomatology, First Hospital of Shanxi Medical University, Taiyuan, Shanxi Province, China. Electronic address:
Achieving desirable clinical outcomes is difficult given the rising number of cases and mortality of oral squamous cell carcinoma. Consequently, developing an efficient drug delivery system for managing cancer progression and metastasis with relatively low toxicity has proven to be highly promising. Initially, carboxymethyl chitosan was covalently modified and partially substituted with folic acid, and subsequently encapsulated as a shell to deliver carboxylated multiwalled carbon nanotubes and their coupled baicalin to form carboxymethyl chitosan-modified folate-targeted carbon nanotubes-baicalein complexes.
View Article and Find Full Text PDFProbing -substituted 4-(5-mercapto-4-ethyl-4H-1,2,4-triazol-3-yl)--phenylpiperdine-1-carboxamides as potent 15-LOX inhibitors supported with ADME, DFT calculations and molecular docking studies.
Heliyon
September 2024
Department of Drug Design and Pharmacology, University of Copenhagen 2, DK-2100, Kobenhavn O, Denmark.
In our continuous efforts to find out leads against the enzyme 15-lipoxygenase (15-LOX), the current study deals with the synthesis of a series of new -alkyl/aralkyl/aryl derivatives of 2-(4-ethyl-5-(1-phenylcarbamoyl)piperidine-4H-1,2,4-triazol-3-ylthio)methylacetamide () with anti-LOX activities. The synthesis was started by reacting phenylisocyanate with isonipecotate that sequentially converted into N-substituted ester (), hydrazide (), semicarbazide () and -ethylated 5-(1-phenylcarbamoyl)piperidine-1,2,4-triazole (). The final compounds, were obtained by reacting with various -alkyl/aralkyl/aryl electrophiles.
View Article and Find Full Text PDFBaicalein analogues as prospective SARS-CoV-2 main protease (M) inhibitors: A dataset of molecular docking-based virtual screening hits.
Data Brief
August 2024
Department of Pharmaceutical Chemistry, School of Pharmacy, IMU University (Formerly known as International Medical University), Kuala Lumpur 57000, Malaysia.
The global coronavirus disease 2019 (COVID-19) pandemic originating from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has exerted profound damage to millions of lives. Baicalein is a flavonoid that has gotten a lot of attention as a possible SARS-CoV-2 main protease (M) inhibitor because it can fight off many different viruses. We prepared and screened three sets of databases, each containing 2563 baicalein analogues, against M using molecular docking simulation.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!